Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2011 June;59(3) > Minerva Cardioangiologica 2011 June;59(3):271-84

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Cardioangiologica 2011 June;59(3):271-84

Copyright © 2011 EDIZIONI MINERVA MEDICA

language: English

Drug eluting stent and coronary chronic total occlusions

Niccoli G., Leo A., Giubilato S., Cosentino N., Minelli S., Galiffa V. A., Crea F.

Institute of Cardiology, Sacro Cuore Catholic University, Rome, Italy


PDF


Chronic total occlusion (CTO) is a common finding on diagnostic coronary angiography and represents one of the most challenging lesion subset in interventional cardiology. The introduction of dedicated guidewires and the development of new techniques have led to improve the success rate in the crossing of CTO lesion while the use of bare metal stent first, and, then, the use of drug eluting stent (DES) have significantly reduced the occurrence of restenosis and the need for target lesion revascularization in short and mid-term follow-up after CTO recanalization. However, new unsolved issues about the use of DES in CTO, that might impact long-term outcome, are emerging. The aim of this article is to review the current stage of knowledge on the application of stents in the treatment of CTO, with a particular attention to DES use and to DES-related challenges.

top of page